Internal Medicine · Orange, NJ
NPI
1265448237
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
85 S Jefferson St, Ste. 3
Orange, NJ, 07050
Phone (973) 673-3522
Groups this clinician bills Medicare through
Medicare paid, 2024
$76K
1,421 services
Medicare patients, 2024
399
Average age 75
Drug cost, 2024
$1.8M
16,934 prescriptions
Company payments, 2025
$2,411
From 23 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Francis J Gialanella was code 99214 (office e&m - established), 719 times for 325 patients. In total Francis J Gialanella billed 1,421 services in 36 codes, and Medicare paid $76K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-10-19.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 719 | 325 | $54.47 | $39K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 234 | 234 | $58.22 | $14K |
| G0008 Administration of influenza virus vaccine | Office | 63 | 61 | $34.37 | $2,166 |
| 90662 Vaccine Product | Office | 59 | 57 | $78.38 | $4,624 |
| 99213 Office E&M - Established | Office | 50 | 46 | $47.52 | $2,376 |
| 96372 Injection Administration | Office | 27 | 13 | $10.09 | $272 |
| 99441 Telephone Services | Office | 21 | 21 | $43.48 | $913 |
| 99204 Office E&M - New | Office | 20 | 20 | $109.41 | $2,188 |
By year: 2022 $107K for 1,742 services; 2023 $79K for 1,463 services; 2024 $76K for 1,421 services.
Medicare prescription drug claims, 2024
In 2024, the drug Francis J Gialanella prescribed most often to Medicare patients was Amlodipine Besylate, with 1,059 prescriptions and refills. In total Francis J Gialanella wrote 16,934 Medicare prescriptions that cost $1.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Amlodipine Besylate Generic | 1,059 | 2,630 | 279 | $7,249 |
| Atorvastatin Calcium Generic | 777 | 1,969 | 216 | $7,437 |
| Levothyroxine Sodium Generic | 511 | 1,199 | 121 | $5,513 |
| Metoprolol Succinate Generic | 454 | 1,093 | 121 | $5,157 |
| Metformin Hcl Generic | 418 | 1,035 | 120 | $2,794 |
| Pantoprazole Sodium Generic | 357 | 827 | 109 | $3,669 |
| Rosuvastatin Calcium Generic | 348 | 930 | 109 | $5,816 |
| Losartan Potassium Generic | 341 | 837 | 101 | $3,385 |
| Glimepiride Generic | 329 | 788 | 84 | $3,423 |
| Alprazolam Generic | 318 | 360 | 80 | $1,220 |
| Gabapentin Generic | 292 | 492 | 85 | $3,483 |
| Meloxicam Generic | 291 | 395 | 89 | $745 |
| Pravastatin Sodium Generic | 289 | 731 | 79 | $4,838 |
| Hydrochlorothiazide Generic | 280 | 664 | 76 | $1,042 |
| Levocetirizine Dihydrochloride Generic | 260 | 420 | 70 | $2,221 |
Brand drugs: 2,387 claims; generic drugs: 14,441 claims; opioid claims: 297.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Francis J Gialanella $2,411 ($2,411 in general payments such as food, travel and fees) from 23 companies. The largest payer was Novo Nordisk Inc with $379.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 19 | $379 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $250 |
| Pfizer Inc. PFE | 20 | $226 |
| Amgen Inc. AMGN | 15 | $212 |
| Lilly USA, LLC LLY | 13 | $201 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 10 | $199 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $162 |
| Novartis Pharmaceuticals Corporation NVS | 7 | $125 |
| Astellas Pharma US Inc 4503.T | 5 | $104 |
| Dexcom, Inc. DXCM | 4 | $88.52 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.